Freeport-McMoRan Inc (FCX.N)
16 Feb 2018
* Indonesia issued the local unit of copper miner Freeport McMoRan Inc with a quota to export 1,247,866 wet metric tonnes (wmt) of copper concentrate up to Feb 15, 2019, a mining ministry official said on Monday.
TORONTO/MELBOURNE As shareholders push the world's cash-rich miners to maintain lush dividends and make the most of existing assets, Glencore is taking a slightly different tactic that positions it for shrewd acquisitions.
* CARL ICAHN SAYS NOW OWNS 4.14 PERCENT STAKE IN FREEPORT-MCMORAN INC AS OF FEB 14 - SEC FILING
(Adds comment, detail) By Melanie Burton MELBOURNE, Feb 15 London copper prices on Thursday rose for a fourth session to their highest in 10 days, supported by a decline in the dollar and robust prospects for global growth. FUNDAMENTALS * LONDON COPPER: In light trading, London Metal Exchange copper had climbed 0.2 percent to $7,180.50 a tonne by 0647 GMT. It earlier hit its highest since Feb. 5 at $7,195. Prices have gained 6.3 percent over the last four sessi
* Indonesia is 'still evaluating' a proposed extension of copper concentrate exports by local unit of Freeport McMoRan Inc , a mining ministry official said on Thursday.
Freeport-McMoRan Inc reinstated its cash dividend on Tuesday, three years after suspending it, reflecting a stronger financial position, improved market conditions and a positive outlook for cash generation.
Feb 6 Freeport-McMoRan Inc reinstated its cash dividend on Tuesday, three years after suspending it, reflecting a stronger financial position, improved market conditions and a positive outlook for cash generation.
* FREEPORT-MCMORAN REINSTATES CASH DIVIDEND ON COMMON STOCK Source text for Eikon: Further company coverage:
BRIEF-Fibrocell Science Says Expect To Initiate A Safety Clinical Trial In 2018 For Fcx-013 Development
* FIBROCELL SCIENCE SAYS EXPECT TO INITIATE A SAFETY CLINICAL TRIAL IN 2018 FOR FCX-013 DEVELOPMENT - SEC FILING Source text for Eikon: Further company coverage:
* FIBROCELL SCIENCE SAYS SUBMITTED INVESTIGATIONAL NEW DRUG APPLICATION FOR FCX-013 FOR TREATMENT OF MODERATE TO SEVERE LOCALIZED SCLERODERMA Source text for Eikon: Further company coverage: